Drugs / Vaginal Lactobacillus capsules
Vaginal Lactobacillus capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05974449 | Aug 2023 → Dec 2025 overdue | female breast carcinoma | The First Affiliated Hospital with Nanjing Medical University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vaginal Lactobacillus capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05974449 ↗ |
| Modality | Other / unclassified | “This product is a micro-ecological preparation made from live Lactobacillus” NCT05974449 ↗ |
| Route | Other | “placing the drug deep into the vagina” NCT05974449 ↗ |